These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 137301)

  • 1. Levodopa and Huntington's chorea.
    Loeb C; Roccatagliata G; La Medica G; Abbruzzese G; Albano C
    J Neurol Neurosurg Psychiatry; 1976 Oct; 39(10):958-61. PubMed ID: 137301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa in Huntingtons chorea.
    Sishta SK; Templer DI
    Can Med Assoc J; 1976 May; 114(9):798-9. PubMed ID: 131644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
    Reuter I; Hu MT; Andrews TC; Brooks DJ; Clough C; Chaudhuri KR
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):238-41. PubMed ID: 10644798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Huntington's chorea and levodopa.
    Schenk G; Leijnse-Ybema HJ
    Lancet; 1974 Mar; 1(7853):364. PubMed ID: 4131222
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebrospinal fluid metabolism of biogenic amines in Huntington chorea].
    Loeb C; Roccatagliata G; Albano C; Lamedica G; Abbruzzese G; Canini S
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 119(2):333-42. PubMed ID: 137520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of fenfluramine in Huntington Chorea].
    Roccatagliata G; Pizio N; Farinini D; Firpo MP; Bartolini A; Bacigalupo F; Albano C
    Rev Neurol (Paris); 1983; 139(10):589-92. PubMed ID: 6196830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
    Davidson DL; Yates CM; Mawdsley C; Pullar IA; Wilson H
    J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
    Mattsson B; Persson SA
    Acta Psychiatr Scand Suppl; 1974; 255():245-59. PubMed ID: 4282556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of Huntington's chorea: a pharmacological and clinical approach to the organization of the basal ganglia].
    Roccatagliata G; Albano C
    Clin Ter; 1980 Aug; 94(3):249-56. PubMed ID: 6450021
    [No Abstract]   [Full Text] [Related]  

  • 14. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
    Vestergaard P; Yates CM
    Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment with disulfiram in huntington's chorea.
    Mattsson B; Bertilsson L
    Acta Psychiatr Scand Suppl; 1974; 255():261-8. PubMed ID: 4282557
    [No Abstract]   [Full Text] [Related]  

  • 16. Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid.
    Nishi K; Kondo T; Narabayashi H; Takubo H; Muramoto S; Araki H
    J Neurol Sci; 1989 Aug; 92(1):65-70. PubMed ID: 2475587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choreic dyskinesia and GABA - pharmaco-clinical approach. Preliminary note].
    Roccatagliata G; Albano C; Besio G; Ivaldi EM
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):63-8. PubMed ID: 153581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa responsive parkinsonism in an adult with Huntington's disease.
    Racette BA; Perlmutter JS
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):577-9. PubMed ID: 9771791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rigid pseudoparkinsonian variant of Huntington's chronic chorea. A case with early onset and the effects of L-dopa treatment.
    Christodorescu D; Costiner E
    Neurol Psychiatr (Bucur); 1979; 17(2):107-11. PubMed ID: 158214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.